Cargando…

893. Evaluating Weight Gain in Treatment-naïve, HIV-infected Patients Started on Antiretroviral Therapy

BACKGROUND: There is increasing evidence that integrase strand transfer inhibitors (INSTIs) are associated with more weight gain when compared to other antiretroviral (ART) classes. Thus, the primary objective of the study was to evaluate the difference in weight gain at 6 and 18 months among treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhry, Nimra, Cani, Eris, Raymond, Lendelle, Park, Tae, Kanter, Timothy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644898/ http://dx.doi.org/10.1093/ofid/ofab466.1088

Ejemplares similares

719. Clinical Outcomes of Single versus Double Anaerobic Coverage for Intra-abdominal Infections
por: Raymond, Lendelle, et al.
Publicado: (2020)

840. Clinical Characteristics of Patients Living with HIV Hospitalized for COVID-19
por: Chaudhry, Nimra, et al.
Publicado: (2021)

242. Association Between Procalcitonin and Antimicrobial Usage in Patients with COVID-19
por: Aly, Mahmoud H, et al.
Publicado: (2022)

881. Long-term Weight Gain After Initiating Combination Antiretroviral Therapy in Treatment-naïve Asian People Living with HIV
por: Ando, Naokatsu, et al.
Publicado: (2021)

893. Occurrence’s Prediction of Surgical Site Infection in Limb Amputation Surgery
por: de Souza, Flávio Henrique Batista, et al.
Publicado: (2020)

951. Weight Gain Associated With Antiretroviral Therapy
por: Patel, Yesha, et al.
Publicado: (2020)

72. Massive Weight Gain in People with HIV (PWH) Starting Initial Antiretroviral Therapy (ART): Risk Factors and Predictive Ability of Early Weight Gain
por: Phupitakphol, Tanit, et al.
Publicado: (2021)

1039. Real World Community-Based HIV Rapid Start Antiretroviral with BFTAF Versus Conventional HIV Antiretroviral Therapy Start – The RoCHaCHa Study, a Pilot Study
por: Zuppelli, Ashley R, et al.
Publicado: (2020)

952. Weight-Gain in Treatment Naive Newly Diagnosed HIV-Infected Persons After Initiation on Integrase Strand Inhibitor Based Treatment Regimens
por: Szep, Zsofia, et al.
Publicado: (2020)

893. Myocarditis and Pericarditis as a Complication of Mpox: An International Case Series and Literature Review
por: Halani, Sheliza, et al.
Publicado: (2023)

107. Impact of Switching to an Antiretroviral Regimen Containing Tenofovir Alafenamide on Weight Gain and Development of Metabolic Side Effects
por: Darnell, Julia, et al.
Publicado: (2020)

835. Improvement in Diet Attenuates Antiretroviral Therapy (ART) Associated Weight Gain in Persons with Human Immunodeficiency Virus (PWH)
por: Patel, Yesha, et al.
Publicado: (2021)

1284. Study of Single Nucleotide Polymorphisms Associated with HIV-1 Set-Point Viral Load in Antiretroviral Therapy-Naïve HIV-Positive Participants of the START Study
por: Ekenberg, Christina, et al.
Publicado: (2018)

1048. Weight Gain after Initiation of Anti-Retroviral Therapy in Acute HIV-1
por: Kaur, Harmanpreet, et al.
Publicado: (2020)

891. Minimum Manufacturing Costs and National Prices for Weight Loss Treatments, as Potential Mitigation for Anti-Retroviral Related Weight Gain in HIV
por: Levi, Jacob, et al.
Publicado: (2021)

Appropriate Time to Start Antiretroviral Therapy in HIV-infected Patients with Penicilliosis marneffei
por: Utkham, Thongchai, et al.
Publicado: (2017)

Treatment modification in HIV-Infected individuals starting antiretroviral therapy between 2011 and 2014
por: Rappold, Michaela, et al.
Publicado: (2014)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

1043. The impact of integrase strand transfer inhibitors (InSTIs) on weight gain among adults with HIV in clinical care
por: Thatipelli, Sneha, et al.
Publicado: (2020)

1049. Weight Gain in Persons Living with HIV (PLWH) Treated with Bictegravir Compared to Other Integrase Strand Transfer Inhibitors
por: Fang, Michelle, et al.
Publicado: (2020)

Determinants of HIV-1 drug resistance in treatment-naïve patients and its clinical implications in an antiretroviral treatment program in Cameroon
por: Zoufaly, Alexander, et al.
Publicado: (2014)

187. The 30-Day Readmission and 30-Day Mortality of Hemodialysis Patients with Antibiotic-Resistant Gram-Negative Bacteremia
por: Oommen, Jomi K, et al.
Publicado: (2019)

333. Weight Gain Among HIV-Infected Patients in Southern India on Treatment with Integrase Strand Transfer Inhibitor-based Antiretroviral Therapy
por: Khan, Rifa, et al.
Publicado: (2019)

Single-tablet regimen is associated with reduced efavirenz withdrawal in antiretroviral naïve or switching for simplification HIV-infected patients
por: Fabbiani, M, et al.
Publicado: (2012)

P893: CARFILZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (KRD) AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS: ITALIAN, MULTICENTER, RETROSPECTIVE EXPERIENCE OUTSIDE OF CLINICAL TRIALS
por: Martino, E. A., et al.
Publicado: (2022)

1522. Predictors of Weight Gain in People Living with HIV
por: Pedersen, Karen B H, et al.
Publicado: (2023)

Comparison of Time to Viral Suppression Among Treatment-Naïve HIV-Infected Adults Initiating Combination Antiretroviral Therapy by Antiretroviral Regimen Class
por: Jacobson, Karen, et al.
Publicado: (2017)

Initiating the antiretroviral therapy in treatment-naïve patients
por: Benea, Elisabeta, et al.
Publicado: (2014)

1020. Higher efavirenz mid-dose plasma concentration is associated with less weight gain among virologically suppressed people living with HIV
por: Huang, Wei-chieh, et al.
Publicado: (2020)

1005. Comparison of Weight Changes in Treatment-Naïve, HIV-Infected Patients Receiving Integrase Inhibitor-Based Therapy Versus Protease Inhibitor-Based Therapy
por: Howe, Zachary, et al.
Publicado: (2020)

Optimal timing for initiation of antiretroviral therapy: a prospective study on treatment naive HIV patients
por: Chakravarty, Jaya, et al.
Publicado: (2012)

557. Evaluation of Clinical Response of a Two Tablet Once Daily Antiretroviral Regimen in Antiretroviral Experienced HIV-Infected Patients
por: Maki, Gina, et al.
Publicado: (2018)

185. Clinical Characterization of Staphylococcus aureus Bacteremia in Children at an Inner-City Community Hospital
por: Oommen, Jomi K, et al.
Publicado: (2019)

1038. Rapid Start: A Changing Algorithm for the Management of HIV Infection
por: Gudipati, Smitha, et al.
Publicado: (2020)

P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS
por: Oriol, Albert, et al.
Publicado: (2023)

1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
por: Ladak, Amber, et al.
Publicado: (2020)

946. Risk factors and Metabolic Implications of Integrase Inhibitor Associated Weight Gain
por: Asundi, Archana, et al.
Publicado: (2020)

1504. Weight Gain and Weight Loss Attempts among People with HIV(PWH) in Louisiana
por: Richey, Lauren, et al.
Publicado: (2023)

Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients
por: Seclén, E, et al.
Publicado: (2010)

Cross-sectional study of HIV living people cohort to specify indications to antiretroviral treatment in naïve patients
por: Pronin, AJ, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ejbc5nf8mhs7vs1knd8spavjmf